Department of Dermatology, University of Eastern Finland and Kuopio University Hospital.
Arch Dermatol Res. 2011 Sep;303(7):499-512. doi: 10.1007/s00403-011-1121-4. Epub 2011 Jan 29.
Increased numbers of mast cells is a typical feature of a variety of human cancers. The major mediators in the secretory granules of the MC(TC) type of mast cells, serine proteinases tryptase and chymase, may be involved in squamous cell carcinoma (SCC) lesions by inducing matrix remodeling and epithelial cell detachment. The objective of this study was to analyze immunohistochemically whether MC(TC) mast cells as well as protease inhibitors, squamous cell carcinoma antigens (SCCAs), are present in the uterine cervical SCC. In addition, the effect of tryptase and chymase on uterine cervical SCC cell lines was studied in vitro. Here we report that tryptase- and chymase-positive mast cells are present in significant numbers in the peritumoral stroma of SCC lesions. Also, weak SCCA-2 immunoreactivity is observed in the SCC lesions, but only SCCA-1 in uterine cervical specimens with nonspecific inflammation. In cell cultures, especially chymase, but not tryptase, was shown to induce effective detachment of viable, growing and non-apoptotic SiHa SCC cells from substratum. Chymase also detached viable ME-180 SCC cells from substratum as well as degraded fibronectin. In contrast, normal keratinocytes underwent apoptotic cell death after similar prolonged chymase treatment. No inhibition of chymase was detected by SiHa cell sonicates nor did these cells express marked SCCA immunopositivity. MC(TC) mast cells containing tryptase and chymase are present in the peritumoral stroma of uterine cervical SCC and the malignant cells are only weakly immunoreactive for the chymase inhibitor SCCA-2. It is chymase that appears to be capable of inducing effective detachment of viable and growing SCC cells and therefore, it may release SCC cells from a tumor leading to spreading of malignant cells.
肥大细胞数量的增加是多种人类癌症的一个典型特征。MC(TC)型肥大细胞分泌颗粒中的主要介质,丝氨酸蛋白酶类胰蛋白酶和糜蛋白酶,可能通过诱导基质重塑和上皮细胞脱落而参与鳞状细胞癌(SCC)病变。本研究的目的是分析 MC(TC)肥大细胞以及蛋白酶抑制剂、鳞状细胞癌抗原(SCCAs)是否存在于子宫颈 SCC 中。此外,还研究了胰蛋白酶和糜蛋白酶对子宫颈 SCC 细胞系的体外作用。本研究报告称,在 SCC 病变的肿瘤周围基质中存在大量的胰蛋白酶和糜蛋白酶阳性肥大细胞。此外,在 SCC 病变中观察到弱的 SCCA-2 免疫反应性,但在非特异性炎症的子宫颈标本中仅存在 SCCA-1。在细胞培养中,特别是糜蛋白酶,但不是胰蛋白酶,被证明能有效地诱导活的、生长的和非凋亡的 SiHa SCC 细胞从基质上脱落。糜蛋白酶还能从基质上分离活的 ME-180 SCC 细胞,并降解纤维连接蛋白。相比之下,正常角质形成细胞在类似的长时间糜蛋白酶处理后发生凋亡细胞死亡。SiHa 细胞超声提取物中未检测到糜蛋白酶的抑制作用,这些细胞也未表达明显的 SCCA 免疫阳性。含有胰蛋白酶和糜蛋白酶的 MC(TC)肥大细胞存在于子宫颈 SCC 的肿瘤周围基质中,而恶性细胞对糜蛋白酶抑制剂 SCCA-2 的免疫反应性较弱。似乎是糜蛋白酶能够有效地诱导活的和生长的 SCC 细胞脱落,因此,它可能会使 SCC 细胞从肿瘤中释放出来,导致恶性细胞的扩散。